ASSESSMENT OF THE CONTRIBUTION OF ALPHA-1-ACID GLYCOPROTEIN TO THE SERUM BINDING OF BASIC DRUGS USING SERUM TREATED WITH SULFOSALICYLIC ACID AND DEAE-CELLULOSE

被引：10

作者：

SUZUKI, Y ^{[1
]}

SUGIYAMA, Y ^{[1
]}

SAWADA, Y ^{[1
]}

IGA, T ^{[1
]}

HANANO, M ^{[1
]}

机构：

[1] UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN

来源：

JOURNAL OF PHARMACY AND PHARMACOLOGY | 1985年 / 37卷 / 10期

关键词：

D O I：

10.1111/j.2042-7158.1985.tb04948.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：712 / 717

页数：6

共 23 条

[1] EFFECTS OF CANCER AND ITS TREATMENTS ON PLASMA-CONCENTRATION OF ALPHA-1-ACID GLYCOPROTEIN AND PROPRANOLOL BINDING [J].

ABRAMSON, FP ;

JENKINS, J ;

OSTCHEGA, Y .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (05) :659-663

[2] BINDING OF BETA-ADRENOCEPTOR BLOCKING-DRUGS TO HUMAN-SERUM ALBUMIN, TO ALPHA-1-ACID GLYCOPROTEIN AND TO HUMAN-SERUM [J].

BELPAIRE, FM ;

BOGAERT, MG ;

ROSSENEU, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (03) :253-256

[3] THE CONTRIBUTION OF ALPHA-1-ACID GLYCOPROTEIN, LIPOPROTEINS, AND ALBUMIN TO THE PLASMA-BINDING OF PERAZINE, AMITRIPTYLINE, AND NORTRIPTYLINE IN HEALTHY MAN [J].

BRINKSCHULTE, M ;

BREYERPFAFF, U .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 314 (01) :61-66

[4]

GLASSON S, 1980, MOL PHARMACOL, V17, P187

[5] ALTERED PLASMA DRUG-BINDING IN CANCER - ROLE OF ALPHA-1-ACID GLYCOPROTEIN AND ALBUMIN [J].

JACKSON, PR ;

TUCKER, GT ;

WOODS, HF .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (03) :295-302

[6] CONTAMINATION OF ALBUMIN BY ALPHA-1-ACID GLYCOPROTEIN [J].

LIMA, JJ ;

SALZER, LB .

BIOCHEMICAL PHARMACOLOGY, 1981, 30 (18) :2633-2636

[7]

LOWRY OH, 1951, J BIOL CHEM, V193, P265

[8] BINDING OF QUINIDINE IN SERA WITH DIFFERENT LEVELS OF TRIGLYCERIDES, CHOLESTEROL, AND OROSOMUCOID PROTEIN [J].

NILSEN, OG ;

LEREN, P ;

AAKESSON, I ;

JACOBSEN, S .

BIOCHEMICAL PHARMACOLOGY, 1978, 27 (06) :871-876

[9]

PIAFSKY KM, 1977, CLIN PHARMACOL THER, V22, P545

[10] DISEASE-INDUCED CHANGES IN THE PLASMA-BINDING OF BASIC DRUGS [J].

PIAFSKY, KM .

CLINICAL PHARMACOKINETICS, 1980, 5 (03) :246-262

← 1 2 3 →